Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
compounds
Press Release
Nov 10, 2010
First Joint Cortex-Servier High-Impact Ampakine Compound Moves Into Phase I Clinical Studies
France's largest privately held pharmaceutical company will move forward into Phase I clinical studies with the jointly-discovered High Impact AMPAKINE® compound S47445 (CX1632.
Read More
First
Prev
1
Next
Last